Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides
U. Schönermarck, E. Csernok, A. Trabandt, H. Hansen1, W.L. Gross
Department of Rheumatology, Medical University of Lübeck and Rheumaklinik Bad Bramstedt, Germany; and 1Department of Biochemistry, University of Kiel, Germany.
ABSTRACT
Objective
To assess circulating immunoregulatory cytokines and
soluble surface markers of T and B cell activation in the plasma
of patients with Wegener's granulomatosis (WG), Churg-Strauss
syndrome (CSS) and microscopic polyangiitis (MPA) during active
and inactive diseas, in order to establish their value in
discriminating between disease entities and as markers of disease
activity.
Methods
Plasma levels of IL-4, IL-5, IL-10, IL-12, IL-13, IFN-g and
soluble CD23, CD26 and CD30 were determined by enzyme-linked
immunosorbent assay in patients with WG (n = 21), CSS (n = 19)
and MPA (n = 14) during active disease and remission.
Results
Concerning cytokines, no differences were observed for IFN-g, IL-4, IL-5 and IL-13. Plasma levels of IL-12 were
decreased in all subgroups of patients. On the contrary, IL-10
levels were significantly elevated only in patients with CSS.
Levels of sCD30 were significantly increased in patients with
active generalized WG and CSS, but not in those with MPA and
localized WG, correlating with the disease extent and activity.
sCD26 levels were markedly decreased in patients with generalized
WG, CSS and MPA and increased towards remission. sCD23 levels
were slightly, but not significantly increased in CSS and
generalized WG.
Conclusion
Regarding the investigated immunoregulatory cytokines
(Th1/Th2 type), only the measurement of plasma levels of IL-10
discriminated CSS from WG and MPA. The reported data could
indicate a similar status of T cell activation in generalized WG
and CSS, and possibly a shift in peripheral immunity towards a
more humoral dominated immune response. The differences observed
between patients with the localized and generalized forms of WG
seem to reflect the clinically known biphasic course of this
disease.
Key words
Vasculitis, ANCA cytokine, soluble CD26, soluble CD30.
Please address correspondence and reprint requests to: E. Csernok, PhD, Rheumaklinik Bad
Bramstedt, D-24572 Bad Bramstedt, Germany.
E-mail: c.moeck@rheuma-zentrum.de
Clin Exp Rheumatol 2000; 18:
457-463.
© Copyright Clinical and Experimental
Rheumatology 2000.